Impact BioMedical Inc. IBO
As ofNov 17, 2026, 3:59 PM EST
- YTD
- -3.44%
- 1 year
- +8.63%
5D +1.04 (+20.27%)
- Market cap
- 53.31M
- EPS (ttm)
- 12.57
- Shares out
- 11.50M
- P/E ratio
- 0.49
- YTD return
- -3.44%
- 1-year return
- +8.63%
- Volume
- 25.18K
- Avg volume
- 18.36K
- Open
- 5.19
- Previous close
- 4.91
- Day's range
- 5.13 – 6.17
- 52-week range
- 2.68 – 9.87
Key statistics
- 50-day average
- 2.23
- 200-day average
- 2.17
- Enterprise value
- 21.75M
- Price / book
- 0.53
- Free cash flow
- -1.33M
- Total cash
- 2.67M
- Total debt
- 8.01M
- Return on equity
- 3.45%
Fundamental scorecard
6 of 25 checks passed on IBO’s reported financials
6of 25 checks passed
- Value 0 of 5
- Growth 2 of 5
- Profitability 1 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
About Impact BioMedical Inc.
Impact BioMedical Inc. focused on discovery, development, and commercialization of products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- impactbiomedinc.com
News
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley's Limited)
CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley's Ltd.
Impact Biomedical Investor News: Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO
Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue
IBO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Impact BioMedical Inc. Is Fair to Shareholders
Your note
Sign in to keep a note on IBO — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Ferguson Wellman Capital Management, Inc. | 0.00% | 36,364 | 52.36K | Sep 29, 2024 |
| HRT Financial LP | 0.00% | 12,502 | 18.00K | Sep 29, 2024 |
| Wells Fargo & Company | 0.00% | 29 | 41 | Sep 29, 2024 |
| Jane Street Group, LLC | 0.00% | 13,361 | 19.24K | Sep 29, 2024 |
| Bank of America Corporation | 0.00% | 2,596 | 3.74K | Sep 29, 2024 |
| Barclays Plc | 0.00% | 1,120 | 1.61K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Balanced Index Fund | 0.00% | 154,000 | 221.76K | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 0.00% | 5,171,052 | 7.45M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.00% | 26,770 | 38.55K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.00% | 5,820 | 8.38K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.00% | 2,449 | 3.53K | Oct 30, 2024 |
